Reece, D E <br/><br/>
Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer.  [electronic resource] 

 -  Bone marrow transplantation  Oct 2000 
 - 729-35 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1702607  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Anti-Idiotypic--therapeutic use<br/>Antigens, Neoplasm--immunology<br/>Antineoplastic Combined Chemotherapy Protocols--immunology<br/>Bone Neoplasms--immunology<br/>Breast Neoplasms--immunology<br/>Cancer Vaccines--immunology<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Immunotherapy<br/>Liver Neoplasms--immunology<br/>Lymphatic Metastasis--immunology<br/>Lymphocyte Activation<br/>Middle Aged<br/>Time Factors<br/>Transplantation, Autologous<br/>Treatment Outcome